Cite
HARVARD Citation
Orlova, R. et al. (2022). Hypothesis for the development of immune-related adverse events in immune checkpoint inhibitors therapy. Cancer treatment and research communications. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Orlova, R. et al. (2022). Hypothesis for the development of immune-related adverse events in immune checkpoint inhibitors therapy. Cancer treatment and research communications. p. . [Online].